Multimedia
Friday
Session 1 - Mutation analysis in Cancer
Lessons from Acute Myeloid Leukaemia
Professor David Linch
University College London, London, UK
Moderator: Professor Adrian Newland
High Throughput Sequencing in Cancer
Dr. Nickolas Papadopoulos
Sidney Kimmel Cancer Center, San Diego, USA
Moderator: Dr. Alison Jones
Saturday
Session 2 - Gene Regulation in Cancer
Expression Profiling in Breast Cancer
Dr. Lodewyk Wessels
The Netherlands Cancer Institute, Amsterdam, The Netherlands
Moderator: Dr. Alison Jones
Epigenetics of Human Cancer
Dr. Peter Jones
USC Keck, University of Southern California, Los Angeles, USA
Moderator: Professor Finbarr Cotter
The role of Micro RNAs in Cancer
Dr. Carlo Croce
Ohio State University, Columbus, USA
Moderator: Professor Carlos Caldas
The role of Notch in malignant disease and its potential as a target for new therapy
Professor Gian Paolo Dotto
Moderator: Professor Asim Khwaja
Session 3 - New Therapeutic Approaches
Angiogenesis and its inhibition in Cancer
Dr. Napoleone Ferrara
Genentech, South San Francisco, USA
Moderator: Dr. Herbert Hurwitz
Biology of metastasis
Professor Kari Alitalo
Haartman Institute, Helsinki, Finland
Moderator: Professor Peter Johnson
Session 4 - The Cancer Stem Cell Debate
Chair: Dr. Richard P. Hill
Evidence that the Leukaemia Stem Cell is a rare cell
Dr. Dominique Bonnet
London Research Institute, London
Evidence that the Cancer Stem Cell is not a rare cell
Dr. Andreas Strasser
Institute of Medical Research, Melbourne, Australia
Pre Dinner Talk
How a Nobel Peace Prize winner is chosen
Professor Ole Mjos
Chairman, Nobel Peace Prize Committee, Norway (2003 - 2008)
Sunday
Session 5 - Viral Oncogenesis
HPV and Cancer
Professor Harald zur Hausen (Nobel Laureate)
German Cancer Research Centre, Heidelberg, Germany
Moderator: Dr. Lynette Denny
Epidemiology of HPV subtypes
Professor Ethel-Michele de Villiers
German Cancer Research Centre, Heidelberg, Germany
Moderator: Dr. Lynette Denny
Session 6
Round Table Discussion on Drug Development
Chair: Professor Hilary Calvert
Use of molecular imaging: Professor Elisabeth De Vries
Assessment of optimal dose: Dr. Rajesh Chopra
Innovative design of phase II Trials: Dr. Jean-Pierre Armand
Registration strategies for targeted therapies: Dr. Philippe Bishop
Novel design of phase III Trials: Professor Jonas Bergh
Monday
Session 7
Kinase Inhibitors in Cancer
Dr. Yosef Yarden
Weizmann Institute, Israel
Moderator: Professor Tim Eisen
Kaposi’s Sarcoma
Professor Chris Boshoff
University College London, London, UK
Moderator: Dr. Zainab Mohamed